Anzeige
Mehr »
Dienstag, 14.07.2026 - Börsentäglich über 12.000 News
Time to Buy! Diese drei Kräfte treiben die Tiefsee-Exploration massiv an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D495 | ISIN: CA13765U2002 | Ticker-Symbol: 8CB0
Frankfurt
13.07.26 | 08:08
1,080 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CANNARA BIOTECH INC Chart 1 Jahr
5-Tage-Chart
CANNARA BIOTECH INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,1401,20017:17

Aktuelle News zur CANNARA BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16:29Stocks in Play: Cannara Biotech Inc. 1
MiCannara Biotech Inc (2): Cannara Biotech to release Q3 results on July 151
02.07.Cannara Biotech Inc (2): Cannara obtains Canadian rights to Ampersand technology1
02.07.Cannara Biotech Inc.: Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand Live Rosin Infusion Technology474MONTREAL, July 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade...
► Artikel lesen
07.05.Cannara Biotech Inc (2): Cannara Biotech closes Medican Organic acquisition1
14.04.Cannara Biotech GAAP EPS of $0.02, revenue of $27.1M1
14.04.Cannara Biotech Inc.: Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec328Delivered strong Q2 financial results: Generated $27.2 million in total net revenues, $11.6 million in gross profit before fair value adjustments or 43% of revenues, $6.0 million in adjusted EBITDA1...
► Artikel lesen
07.04.Cannara Biotech Inc (2): Cannara Biotech to release fiscal Q2 results April 141
CANNARA BIOTECH Aktie jetzt für 0€ handeln
07.04.Stocks in Play: Cannara Biotech Inc.1
19.03.CEO Clips: Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange375Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis...
► Artikel lesen
17.03.Toronto Stock Exchange: Cannara Biotech Inc. (LOVE) Opens the Market454Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Donald Olds, Lead Director and Chairman of the Audit and Governance Committee, Cannara Biotech Inc. ("Cannara" or the "Company") (TSX: LOVE)...
► Artikel lesen
27.02.Cannara Biotech Inc (2): Cannara receives final OK to transfer shares to TSX1
27.02.Cannara Biotech Inc (2): Cannara Biotech to delist from TSX-V2
26.02.Cannara Biotech Inc.: Cannara Announces Graduation to the Toronto Stock Exchange 283MONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis...
► Artikel lesen
19.02.Cannara Biotech Inc (2): Cannara Biotech three-million-share private placement4
13.02.Cannara Biotech Inc (2): Cannara Biotech to host investor webcast Feb. 191
12.02.Cannara Biotech Inc.: Cannara to Host Investor Webcast on February 19th, 20261
04.02.Cannara Biotech Inc (2): Cannara Biotech closes $6.3-million private placement2
02.02.Cannara Biotech Q1 2026 slides: Record margins and Quebec market leadership3
02.02.Cannara Biotech überzeugt mit Rekordmargen und Marktführerschaft in Quebec2
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1